Autologous TIL 1383I-expressing T-cell therapy (Loyola University of Chicago)

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameAutologous TIL 1383I-expressing T-cell therapy (Loyola University of Chicago)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionCell replacementsAnti-TYRP1
TargetsTyrosinase-related protein 1
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLoyola University Chicago
China Registration ClassN/A

Develop Information

Active CompaniesLoyola University
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A